TrialThe Journal of clinical investigation1993

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

M A Nauck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.